| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5927189 | American Heart Journal | 2014 | 8 Pages |
Abstract
The AIDA trial will provide the first randomized direct comparison between the everolimus-eluting bioresorbable vascular scaffold and the everolimus-eluting metallic stent in contemporary percutaneous coronary intervention practice.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Pier MD, Maik J. MD, Robin P. MD, Mariëlla E.C.J. MD, E. Karin PhD, MD, Jan PhD, MD, Marije M. PhD, MD, Karel T. MD, PhD, Jan G.P. PhD, Jan J. MD, PhD, Robbert J. MD, PhD, José P.S. MD, PhD, Joanna J. MD, PhD,